Third Harmonic Bio, Inc. (THRD) Analyst Estimates Quarterly - Discounting Cash Flows
THRD
Third Harmonic Bio, Inc.
THRD (NASDAQ)
Period Ending: 2025
12-31
2025
09-30
2025
06-30
2025
03-31
2024
12-31
2024
09-30
2024
06-30
Number of Analysts 0 0 0 0 0 0 0
Estimated Revenue
Low 0 0 0 0 0 0 0
Average 0 0 0 0 0 0 0
High 0 0 0 0 0 0 0
Estimated EBITDA
Low 0 0 0 0 0 0 0
Average 0 0 0 0 0 0 0
High 0 0 0 0 0 0 0
Estimated EBIT
Low 0 0 0 0 0 0 0
Average 0 0 0 0 0 0 0
High 0 0 0 0 0 0 0
Estimated Net Income
Low -8.53 -8.09 -10.33 -11.92 -16.91 -12.36 -11.64
Average -8.53 -8.09 -10.33 -11 -14.94 -12.36 -11.64
High -8.53 -8.09 -10.33 -9.78 -13.37 -12.36 -11.64
Estimated SGA Expenses
Low 0 0 0 0 0 0 0
Average 0 0 0 0 0 0 0
High 0 0 0 0 0 0 0
Estimated EPS
Low -0.19 -0.18 -0.23 -0.265 -0.409 -0.299 -0.287
Average -0.19 -0.18 -0.23 -0.245 -0.362 -0.299 -0.287
High -0.19 -0.18 -0.23 -0.218 -0.324 -0.299 -0.287
discounting cash flows home logo

Discounting Cash Flows

Are you finding our services helpful? Review us on trustpilot logo Trustpilot
Have a question? Contact us
Want to become our sponsor?
Check out our Affiliate Program